相关实验视频
Updated: Sep 11, 2025

10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
11.0K
按需活跃:针对耐药格兰氏阴性病原体的精确前药物策略
Seyed Majed Modaresi1, Melis N Anahtar2, Aarti Krishnan3
1Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Institute for Medical Engineering and Science and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02215, USA.
Cell host & microbe
|August 14, 2025
概括
研究人员开发了一种新型前药,模仿宿主防御. 这种精确的抗生素疗法在酸性感染部位中激活,有效清除格拉姆阴性病原体和生物膜,而不会促进抗生素耐药性.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 抗生素耐药性是一个日益增长的全球健康威胁.
- 目前的抗生素往往缺乏特异性,导致附带损害和耐药性发展.
- 主体防御 (HDPs) 提供了一个有前途的替代品,因为它们的广谱活性和耐药性的低倾向.
研究的目的:
- 开发一种模仿HDP活动的新型前药.
- 为了在感染部位实现治疗剂的有针对性的激活.
- 评估对抗格拉姆阴性病原体和生物膜的疗效,同时评估耐药性潜力.
主要方法:
- 设计和合成一个模仿HDP的前药物.
- 在酸性环境中进行体外激活研究,模仿感染部位.
- 在体外和体外对抗格兰阴性细菌和生物膜的有效性测试.
- 对细菌群体中耐药性发展的评估.
主要成果:
- 前药在酸性条件下被选择性激活.
- 证明了强大的抗微生物活性对抗格兰氏阴性病原体.
- 成功地根除了预先形成的细菌生物膜.
- 在治疗的细菌菌株中没有观察到显著的耐药性.
结论:
- 这种新型的模仿HDP的前药物代表了精确抗生素治疗的有希望的战略.
- 针对感染部位的向激活提高了疗效,并最大限度地减少了非向效应.
- 这种方法提供了一种潜在的解决方案,用于对抗抗性抗性的风险降低的格拉姆阴性感染和生物膜.
相关概念视频
Prodrugs
2.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.8K
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Development of Antibiotic Resistance
197
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
197
Antibiotic Selection
55.3K
Overview
55.3K

